Engineered T Cells Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 69876 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Engineered T Cells Market - Overview
        1.1 Definitions and Scope
2. Engineered T Cells Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Engineered T Cells Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Engineered T Cells Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Engineered T Cells Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Engineered T Cells Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Engineered T Cells Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Engineered T Cells Market - By Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Segment Analysis
            8.3.1 Chimeric Antigen Receptor Modified T Cell
            8.3.2 T Cell Receptor Modified T Cell
            8.3.3 Tumor Infiltrating Lymphocyte
9. Engineered T Cells Market - By End User (Market Size -$Million / $Billion)
        9.1 Hospital
        9.2 Cancer Research Center
        9.3 Clinic
10. Engineered T Cells - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Lung Cancer
            10.3.2 Breast Cancer
            10.3.3 Colorectal Cancer
            10.3.4 Melanoma
            10.3.5 Leukemia
            10.3.6 Others Application
11. Engineered T Cells- By Geography (Market Size -$Million / $Billion)
        11.1 Engineered T Cells Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Engineered T Cells- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Engineered T Cells- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Engineered T Cells - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Engineered T Cells - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Engineered T Cells Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Engineered T Cells Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Engineered T Cells Market - Key Company List by Country Premium
15. Engineered T Cells Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Autolus Limited
        15.3 Bellicum Pharmaceuticals, Inc
        15.4 Cell Medica Limited
        15.5 Eli Lilly And Company
        15.6 Gilead Sciences, Inc
        15.7 Juno Therapeutics, Inc
        15.8 Novartis Ag
        15.9 Oxford Biomedica Plc
        15.10 Pfizer Inc
        15.11 Precision Bioscience Inc
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Engineered T Cells Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Engineered T Cells Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Engineered T Cell Market, By Type Market 2019-2024 ($M)
1.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Global Industry Research
1.1.1 And Opportunity Market 2019-2024 ($M)
1.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Global Industry Research
1.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Global Industry Research
2.Global Engineered T Cell Market, By End User Market 2019-2024 ($M)
2.1 Hospital Market 2019-2024 ($M) - Global Industry Research
2.2 Cancer Research Center Market 2019-2024 ($M) - Global Industry Research
2.3 Clinic Market 2019-2024 ($M) - Global Industry Research
3.Global Engineered T Cell Market, By Type Market 2019-2024 (Volume/Units)
3.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 (Volume/Units) - Global Industry Research
3.1.1 And Opportunity Market 2019-2024 (Volume/Units)
3.2 T Cell Receptor Modified T Cell Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 Tumor Infiltrating Lymphocyte Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Engineered T Cell Market, By End User Market 2019-2024 (Volume/Units)
4.1 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Cancer Research Center Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Clinic Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Engineered T Cell Market, By Type Market 2019-2024 ($M)
5.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
5.1.1 And Opportunity Market 2019-2024 ($M)
5.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
5.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Regional Industry Research
6.North America Engineered T Cell Market, By End User Market 2019-2024 ($M)
6.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
6.2 Cancer Research Center Market 2019-2024 ($M) - Regional Industry Research
6.3 Clinic Market 2019-2024 ($M) - Regional Industry Research
7.South America Engineered T Cell Market, By Type Market 2019-2024 ($M)
7.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
7.1.1 And Opportunity Market 2019-2024 ($M)
7.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
7.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Regional Industry Research
8.South America Engineered T Cell Market, By End User Market 2019-2024 ($M)
8.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
8.2 Cancer Research Center Market 2019-2024 ($M) - Regional Industry Research
8.3 Clinic Market 2019-2024 ($M) - Regional Industry Research
9.Europe Engineered T Cell Market, By Type Market 2019-2024 ($M)
9.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
9.1.1 And Opportunity Market 2019-2024 ($M)
9.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
9.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Regional Industry Research
10.Europe Engineered T Cell Market, By End User Market 2019-2024 ($M)
10.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
10.2 Cancer Research Center Market 2019-2024 ($M) - Regional Industry Research
10.3 Clinic Market 2019-2024 ($M) - Regional Industry Research
11.APAC Engineered T Cell Market, By Type Market 2019-2024 ($M)
11.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
11.1.1 And Opportunity Market 2019-2024 ($M)
11.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
11.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Regional Industry Research
12.APAC Engineered T Cell Market, By End User Market 2019-2024 ($M)
12.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
12.2 Cancer Research Center Market 2019-2024 ($M) - Regional Industry Research
12.3 Clinic Market 2019-2024 ($M) - Regional Industry Research
13.MENA Engineered T Cell Market, By Type Market 2019-2024 ($M)
13.1 Chimeric Antigen Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
13.1.1 And Opportunity Market 2019-2024 ($M)
13.2 T Cell Receptor Modified T Cell Market 2019-2024 ($M) - Regional Industry Research
13.3 Tumor Infiltrating Lymphocyte Market 2019-2024 ($M) - Regional Industry Research
14.MENA Engineered T Cell Market, By End User Market 2019-2024 ($M)
14.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
14.2 Cancer Research Center Market 2019-2024 ($M) - Regional Industry Research
14.3 Clinic Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Engineered T Cells Market Revenue, 2019-2024 ($M)
2.Canada Engineered T Cells Market Revenue, 2019-2024 ($M)
3.Mexico Engineered T Cells Market Revenue, 2019-2024 ($M)
4.Brazil Engineered T Cells Market Revenue, 2019-2024 ($M)
5.Argentina Engineered T Cells Market Revenue, 2019-2024 ($M)
6.Peru Engineered T Cells Market Revenue, 2019-2024 ($M)
7.Colombia Engineered T Cells Market Revenue, 2019-2024 ($M)
8.Chile Engineered T Cells Market Revenue, 2019-2024 ($M)
9.Rest of South America Engineered T Cells Market Revenue, 2019-2024 ($M)
10.UK Engineered T Cells Market Revenue, 2019-2024 ($M)
11.Germany Engineered T Cells Market Revenue, 2019-2024 ($M)
12.France Engineered T Cells Market Revenue, 2019-2024 ($M)
13.Italy Engineered T Cells Market Revenue, 2019-2024 ($M)
14.Spain Engineered T Cells Market Revenue, 2019-2024 ($M)
15.Rest of Europe Engineered T Cells Market Revenue, 2019-2024 ($M)
16.China Engineered T Cells Market Revenue, 2019-2024 ($M)
17.India Engineered T Cells Market Revenue, 2019-2024 ($M)
18.Japan Engineered T Cells Market Revenue, 2019-2024 ($M)
19.South Korea Engineered T Cells Market Revenue, 2019-2024 ($M)
20.South Africa Engineered T Cells Market Revenue, 2019-2024 ($M)
21.North America Engineered T Cells By Application
22.South America Engineered T Cells By Application
23.Europe Engineered T Cells By Application
24.APAC Engineered T Cells By Application
25.MENA Engineered T Cells By Application
26.Autolus Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bellicum Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Cell Medica Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Gilead Sciences, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Juno Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Oxford Biomedica Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Precision Bioscience Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)